Collaboration offers therapeutic developments in nuclear medicine 

Oncodesign, Covalab, CheMatech and ABX-CRO have partnered to launch the DRIVE-MRT (Molecular RadioTherapy) solution. Designed to offer therapeutic development in nuclear medicine, this encompasses theranostics, from therapeutic target validation, radiolabeled biological vector generation, lead optimisation, preclinical candidate drug generation and IND, to the design and management of clinical trials. 

DRIVE-MRT is based on the companies’ joint expertise in nuclear medicine. It covers technologies related to the validation of targets, the generation and optimisation of vectors, the radiochemistry and PET / SPECT imaging techniques, small animal and clinical dosimetry, and a dedicated support for regulatory and clinical studies specific to radiopharmaceuticals. 

DRIVE-MRT aims to provide clients with innovative technological platforms and corresponding expertise at each validation step in the development of theranostic drug candidates.  

“We can now offer to our pharmaceutical clients a full-continuum, premium radiopharmaceutical drug discovery engine, from preclinic to clinic, together with leading partners”, said Fabrice Viviani, General Manager and Head of the Oncodesign service business unit. 

“Covalab is pleased to be a part of this unique DRIVE-MRT project in which we are very keen to bring our know-how and innovative platforms in DNA immunisation, nanobodies, humanisation, etc. This will help in developing innovative molecules for the immunodiagnostic and immunoradiotherapy markets, which are gaining increasing attention from pharmaceutical companies,” said Meddy El Alaoui, CSO at Covalab. 

Image credit: Oncodesign

Related Articles

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free